It wasn’t long ago that the concept of holding an anatomically correct model of your own heart in your hand was foreign. Today, surgeons are beginning to order replicas of patient organs to plan and practice the most precise procedures. Experts on this panel will discuss the clinical and market expectations for taking surgical planning to a new level.
Moderator: David Cassak, Managing Partner, Innovation in Medtech LLC
Jihad Kaouk, MD, Institute Vice Chair for Surgical Innovations
Director, Center for Laparoscopic & Robotic Surgery, Glickman Urological & Kidney Institute, Cleveland Clinic
Karl West, Director, Medical Device Solutions, Cleveland Clinic
Jacques Zaneveld, PhD, CEO, Lazarus 3D Printing
Nizar Zein, MD, Chair, Global Patient Services, Cleveland Clinic
Why do some nutritional therapies work for some and not others? Are there ideal nutrients that will keep me healthier? Can certain foods reverse my particular disease? Some say the answers to these questions lie in our genes. Experts on this panel will sort through the hype, the science, and the business of nutrigenomics.
Moderator: Mark Hyman, MD, Director, Center for Functional Medicine, Cleveland Clinic
Jeff Bland, PhD, Founder & President, Personalized Lifestyle Medicine Institute
Nathan Price, PhD, Associate Director & Professor, Institute for Systems Biology
Raymond Rodriguez, PhD, Molecular & Cellular Biology, UC Davis
The patient journey is changing. Rather than waiting for a disease to take hold to get help, genetic tests can indicate the tiniest of breadcrumbs that will lead to disease. Experts will discuss the business opportunities for these tests, and how they can inform the earliest of treatment.
Moderator: Gerry McDougall, Partner, PricewaterhouseCoopers
Helmy Eltoukhy, PhD, Co-founder & CEO, Guardant Health
Charis Eng, MD, PhD, Chair, Genomic Medicine Institute, Cleveland Clinic
David McKee, President & CEO, Family Care Path
Alan Wright, MD, CMO, Roche Diagnostics
While genomics and precision medicine offer so much hope for patient care, how can clinicians be expected to make definitive sense of all this data? Panelists will discuss the latest AI and Decision Support technologies that can help clinicians avoid information overload.
Moderator: Joe Cunningham, MD,Managing Director, Santé Ventures
Joel Diamond, MD, CMO, 2bPrecise
Manuel J. Glynias, President & CEO, GenomOncology
Corey van der Wal, Director,ProductManagement, Syapse
Christina Waters, PhD, Executive in Residence, Life Sciences, Innovation Institute
In medicine, a picture is worth a lot more than a thousand words. Clinicians are using images to find new markers that can guide treatment decisions, as well as guide surgery in real-time. This panel will discuss some of the latest technologies, opportunities, and challenges to be overcome in image-based precision medicine.
Moderator: Francis Papay, MD, Chair, Dermatology & Plastic Surgery Institute, Cleveland Clinic
Stephen Grobmyer, MD, Director, Breast Services, Cleveland Clinic
Yang Liu, PhD Assistant Professor, Department of Biomedical Engineering, University of Akron
Rick Mangat, PhD, President & CEO, NOVADAQ
Sarah Moore, SVP, Advanced Therapies, North America, Siemens Healthineers
Peter Tippett, MD, PhD Founder & CEO, HealthCelerate
Devices that break down barriers were among the winning entries at this past weekend’s third annual Cleveland Medical Hack-a-thon.
Cleveland Clinic's Medical Innovation Summit, slated for Oct. 23 to Oct. 25 in downtown Cleveland, will focus on advancements in genomics and precision medicine.
Genomics and precision medicine will be the focus of Cleveland Clinic Medical Innovation Summit, taking place Monday through Wednesday, at the Huntington Convention Center in downtown Cleveland. Green is a featured speaker at the summit.
The Cleveland Medical Hackathon is Oct. 21-22 at the Global Center for Health Innovation in downtown Cleveland. Think of it as a prelude to the Cleveland Clinic Medical Innovation Summit, which begins Oct. 23 and runs through Oct. 25 at the same location.
This potentially transformative discipline is the subject of the Cleveland Clinic's Medical Innovation Summit, to be held Oct. 23-25 downtown. The summit is set to gather more than 2,000 health care and business leaders, among them Dr. Charis Eng, founder of the Clinic's Genomic Medicine Institute (GMI). Eng is a firm believer in the promise of genomics and precision medicine, having identified four of 10 genes known to be associated with breast cancer and another six connected to Cowden syndrome, a disorder that carries high risk of breast, thyroid and other cancers.
Gene therapy, artificial intelligence and customized implants are among the topics that will be discussed at the annual Cleveland Clinic's Medical Innovation Summit, coming this fall to downtown Cleveland.
Precision Medicine Policy Keynotes
Precision Medicine Policy: Can the Government Cure Cancer?
Precision Squared: Population Management Meets Personalized Medicine
Psychological Safety - A New Safety Metric
Special Performance: Chairty Tillemann-Dick
Intro & Welcome
The State of Healthcare Innovation: A Pharma Perspective
Hype, Hope, and the Bottom Line: Reimbursement Strategies For Genomic Innovation
Genomics, Advanced Imaging, and the Future of Medicine
Breaking the Code: Will Next-Generation Sequencing Bring Genomis to the Mainstream
Zeroing in on Disease: The Latest Tools in risk Stratification and Early Detection